Andrea Newkirk
Stock Analyst at Goldman Sachs
(3.01)
# 1,268
Out of 5,152 analysts
4
Total ratings
100%
Success rate
93.92%
Average return
Main Sectors:
Stocks Rated by Andrea Newkirk
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SDGR Schrödinger | Initiates: Neutral | $19 | $13.03 | +45.82% | 1 | Sep 30, 2025 | |
| RVMD Revolution Medicines | Maintains: Buy | $65 → $73 | $99.64 | -26.74% | 2 | Sep 12, 2025 | |
| ALKS Alkermes | Initiates: Buy | $43 | $28.35 | +51.68% | 1 | Jul 15, 2025 |
Schrödinger
Sep 30, 2025
Initiates: Neutral
Price Target: $19
Current: $13.03
Upside: +45.82%
Revolution Medicines
Sep 12, 2025
Maintains: Buy
Price Target: $65 → $73
Current: $99.64
Upside: -26.74%
Alkermes
Jul 15, 2025
Initiates: Buy
Price Target: $43
Current: $28.35
Upside: +51.68%